Time to Throw Chevron Overboard: Loper Bright Enterprises v. Raimondo


By John A. Sparks


Suppose that you owned a manufacturing business for which the government prescribed certain production regulations, and suppose, further, that the government demanded that you provide office space for a federal observer to monitor your operation. Finally, suppose that the government now claimed that you had to pay that observer's salary. This is essentially what a group of commercial Atlantic herring fisheries are now facing and what led them to bring legal action asking the courts to rein in this regulatory overreach. The Supreme Court has agreed to hear their case and others that are related.

Here are the facts: In 1976, Congress passed, and President Gerald Ford signed, the Magnuson-Stevens Act (MSA), which targeted what is commonly called “overfishing.” The stated purpose was to promote recreational and commercial fishing “under sound conservation and management principles.” The Secretary of Commerce was to be the chief overseer, but he delegated the task of regulation to an administrative agency, the National Marine Fisheries Service (NMFS). In only three specific instances in the MSA did Congress expressly require the fishing industry to cover the cost of compliance observers. One was the North Pacific region, mostly fished by large enterprises. Another was on foreign vessels fishing in our waters. The last was a complex arrangement called the “limited access program” which established fishing quotas for certain fishing companies. The remainder of commercial fishing businesses could be required to have observers on board, but the government appropriated funds to pay them, not the businesses.

In summary then, the MSA did not mandate industry-funded inspectors in other fishing areas besides the three just mentioned. Nevertheless, the NMFS issued new regulations which would impose just such a plan on a major but completely different fishing local—namely, the New England area (Maine, New Hampshire, Massachusetts, Rhode Island, and Connecticut).

The plaintiffs in this case are owners of small enterprises fishing in the New England waters. They strenuously object to the additional financial burden that this will impose on what are largely family-owned and operated businesses. These fishing firms have already lived through losing some of the limited crew space on their boats in order to accommodate the compliance observers. But paying the salaries of these regulatory agents exceeds the limits of their endurance. They have said, in effect, this far and no farther. Even using the NMFS’s own estimates, these small family ventures will have to pay $710 per day to compensate the at-sea monitor, thus reducing the profit return to the owner by approximately 20%. Failure to pay the monitoring inspector is not an option because such a refusal would mean completely losing the right to fish in the New England area.

One would expect that without new, express congressional authorization for this costly and intrusive requirement, the judicial determination of their cases would be a simple one. Silence on the part of Congress in this case means that the regulatory agency is foreclosed from acting until Congress legislates to include the New England area in the funding requirement.

Nevertheless, the lower courts ruled against the private fishing companies. Why? Both courts that heard the case—the Federal District Court and the DC. Circuit Court of Appeals—relied upon a 1984 Supreme Court case titled Chevron USA, Inc. v. Natural Resources Defense Council, Inc. The opinion created a legal doctrine called “judicial deference.”

What is judicial deference? It often surfaces when a regulatory agency proposes a new policy or action which it claims is within its administrative discretion because Congress has not spoken directly on the issue, or, if it has, it has spoken “ambiguously.” The regulated parties who stand to be harmed by the new regulation challenge the agency’s interpretation in court. The Chevron opinion, however, favors the administrative agency. It maintains that a court, hearing such a case, should defer to the agency’s interpretation if that interpretation is not unreasonable. The court should not substitute its own interpretation of what the statute says or does not say for the regulatory agency’s interpretation.

Back to the fishing case. The complaining fishing companies say that Chevron should not apply at the very least. Congress’ intention is clear. It authorized industry-funded observers in just three cases. Congress has spoken and it has spoken without ambiguity. Until it speaks otherwise, NMFS cannot override that congressional clarity.

To further buttress their case, the plaintiff fisheries rightfully point out that during the four decades since Chevron, whenever there have been legislative attempts to expand the authority for industry-funded monitors/observers, the legislation has failed. Furthermore, NMFS argues that it is required to act with new regulations because Congress has not fully funded more observers. That argument, say the fishing companies, is glaring proof of the restraint of the “power of the purse” to curb overly zealous regulatory agencies.

This case and others being heard this term have to do with what is often referred to as the growth of the administrative or regulatory sector. Chevron has been a large part of the reason for that growth. After Chevron, reliance of the courts upon this doctrine of judicial deference naturally has encouraged greater regulatory boldness. In many cases, administrative agencies have claimed power well beyond what Congress intended. At the same time, the Chevron doctrine has diminished the courts’ power to curb such expansion.

More fundamentally, as law Professor Philip Hamburger has pointed out, the Chevron decision was constitutionally wrong because it took away the rightful authority of the courts to engage in the interpretation of statutes, arguably one of their most important functions as appellate courts. Though the Supreme Court has declined to use Chevron in recent cases where litigants raised it, what is needed now is for Chevron to be overruled. Otherwise, lower courts will feel bound to apply it. The regulatory state will continue to gradually take more and more of the liberty of American citizens.

As Professor Hamburger puts it forcefully when referring to the administrative/regulatory sector, “It now has become a feral, brazenly overrunning constitutional limits and threatening our civil liberties.”

Dr. John A. Sparks is the retired Dean of Arts & Letters, Grove City College and a Fellow in the Institute for Faith and Freedom. He is a member of the state bar of Pennsylvania and a graduate of Grove City College and the University of Michigan Law School. Sparks writes regularly for the Institute on Supreme Court developments.



More Resources


01/10/2025
Carter Funeral Brings Rare, Needed Vision of Peace


more info


01/10/2025
Three More Biden Deceptions
The president can believe what he wants to believe, and at this point, there appears to be no convincing him otherwise.

more info


01/10/2025
A Nation Suffers Whiplash Between Biden and Trump
On any other day this might seem strange

more info


01/10/2025
Biden Admin Told Us To Censor True Info


more info


01/10/2025
Facebook Admits Error--'Fact Checkers' Still Complicit
Mark Zuckerberg seems to want to reverse Facebook's censorship efforts, but those publications that participated in the program are complicit.

more info


01/10/2025
In Defense of DEI
DEI refers to three simple but important words: diversity, equity and inclusion. These three values are indispensable

more info


01/10/2025
Woke Religion Burned People's Homes to the Ground
The wildfire devastation of Los Angeles occurred largely as a result of people in power adhering blindly and madly to a very bad religion.

more info


01/10/2025
LA's Poor Communication Should Have Residents Fuming


more info


01/10/2025
Republican Party's New Ground Game


more info


01/10/2025
Opening the DNC's Black Box
Why we're publishing a previously undisclosed list of all 448 members of the Democratic National Committee

more info


01/10/2025
The Most Under-Reported Story About Biden
What was the most under-reported news story during the Biden presidency? In the last week or so, there has been a sudden burst of recognition of the extent to which Democrats and the media worked together to cover up Biden's progressing cognitive decline. One media figure after another has com

more info


01/10/2025
Biden Is No Carter
In terms of character the 46th president doesn't come close to matching the 39th.

more info


01/10/2025
Biden Says He Could've Beaten Trump. That's Delusional
Not only is Biden overestimating his political skills, he's also ungraciously insulting his vice president.

more info


01/10/2025
Dresden in Los Angeles and Our Confederacy of Dunces
LA is burning. And the derelict people responsible are worried that they are found out as charlatans and empty suits.

more info


01/10/2025
The L.A. Apocalypse Was Entirely Predictable
Today on TAP: The hills above my hometown regularly catch fire, and developers regularly build there nonetheless.

more info



Custom Search

More Politics Articles:

Related Articles

5 Financial Pressure Points To Evaluate During COVID Times


Financial pressure is a part of life for most people, and now the COVID-19 pandemic has brought new financial pressure points or exacerbated existing ones for many individuals and families.

Why Are People Complaining About Innovative COVID Treatments?


Gilead Sciences just announced it will charge $3,120 for a full course of Remdesivir, the first new FDA-approved treatment for COVID-19. Some knee-jerk members of Congress like Lloyd Doggett (D-Tex.) immediately condemned that price tag as "outrageous." The Institute for Clinical and Economic Review, a left-leaning nonprofit that releases its own recommendations of "fair" drug prices, claimed that Gilead could afford to price Remdesivir as low as $10 per course of treatment -- the cost of the raw ingredients used to make the drug.

Proposed Healthcare Reforms Will Not Help the Latinx Community


Joe Biden is officially the Democratic presidential nominee, all thanks to his moderate reputation.

Trade Enforcement Can Accelerate America's Economic Recovery


The stock market has largely rebounded from COVID-19 and American retail sales are improving steadily. Even more encouraging is that the U.S. unemployment rate fell for the fifth consecutive month in September. Each of these gains are sure signs that the Trump administration's economic response to the coronavirus crisis is working.

Drug Price Controls: Right Objective, Wrong Solution


This month, President Trump signed an executive order to reduce Medicare spending on prescription drugs. For each medication, Medicare will pay no more than the lowest price available in other developed countries.

Keep Thanksgiving, Family and Friends Alive


Joe Biden or Donald Trump will never visit me in my home, stand beside me at the funeral home or dance at my wedding. I will not be receiving any calls from either of them to pray for me during sickness or to check on how my children are doing. I probably will never sit in a room with them to visit, laugh and tell funny stories or just to hang out over a cup of coffee. I do not personally know either one. I welcome the opportunity to visit with either of them, but doubt it will happen.

The "E" Stands for “Excellence:” Remembering Walter E. Williams


Walter E. Williams, prolific author, piercing cultural commentator, old school economist (that’s a good thing), devoted husband, loving father, and long-time friend of Grove City College has passed from this world.

How Congress Can Really Fix Surprise Billing


House and Senate leaders recently agreed on legislation to end surprise medical bills as part of a big coronavirus relief package. President Trump signed it into law at the end of December.

A Federal Rule Will Reverse Strides in Cancer Treatment


"You've got cancer." That's one of the scariest sentences in the English language.

Biden Must Restore Seniors' Access to Essential Medicines


On January 19, Medicare officials announced a new payment model that could wreak havoc on the chronically ill.

Violence In America, Don't Be Surprised


The most recent attack at the United States Capitol will most likely insure a permanent fence and additional security. The attack which resulted in the loss of life for a long serving Capitol police officer and the attacker is another senseless violent act.

Protecting the Innovation that Protects Global Health


The most far-reaching healthcare policy decision of 2021 won't be made in Congress or the White House. It will be made at the World Trade Organization, which is considering a petition to waive all patent rights on Covid-19 vaccines.

Don't Repeat Europe's Vaccine Catastrophe


For many Americans, the calamitously slow vaccine roll-out in countries like Germany, France, and Italy comes as a surprise. After all, in the early days of the pandemic, Europe's response to the crisis seemed highly competent, especially compared to the United States.

A Full Plate for the New U.S. Trade Czar


The newly confirmed U.S. trade representative, Katherine Tai, is about as qualified as a person can be for the job. Which is a good thing, because she already faces a series of challenges.

Don't Let the US Import Europe's Failed Cancer Policies


With a majority in both the House and Senate and control of the Oval Office, Democratic leaders are excited about the prospect of making significant changes. One good example of this is the House Democrats' "Lower Drug Costs Now Act."